Higher risk seen for asthma, atopic eczema, and allergic rhinoconjunctivitis

Significantly greater ACR20 response rates seen at week 16 for 30 and 60 mg QD versus placebo; response maintained or improved at 52 weeks

An outbreak in Chicago of the virus formerly called monkeypox has public health officials on edge

Increased risk seen for psoriatic and rheumatoid arthritis, and ankylosing spondylitis

39 percent of patients had fewer than five lesions; papules, vesicles, pustules predominated in first five days of infection

All primary and key secondary end points met in two phase 3 trials of adults with PN with ≥20 nodules

Intervention group showed greater improvement in Dermatology Life Quality Index score at 13 weeks and in secondary end points

High-intensity focused electromagnetic field technology with radiofrequency reduces VAT at three months; reduction maintained at six months

Greater reduction seen in International HS Severity Score System and in Dermatology Life Quality Index in combination group

The most diagnostic improvement was seen for dermatologists with less dermoscopy experience cooperating with the CNN

Since the outbreak began last May, more than 30,000 people have been infected with the virus and 42 people have died

Patient-centered methodology-generated probabilities better identify patients eligible for sentinel lymph node biopsy than those generated by conventional logistic regression analysis

Exposure to coniferous, mixed forests and agriculture areas associated with elevated eczema risk

Positive association seen between mothers' Family Dermatology Life Quality Index scores and children's Psoriasis Area Severity Index scores

Intraclass correlation coefficient 0.78 between clinical and photographic Psoriasis Area and Severity Index

Definition includes five domains of management of clinical symptoms, psychosocial elements, QoL, treatment, health care team support

Significant reductions seen over placebo for 80 mg gusacitinib in mTLSS, PGA, HECSI as early as week 2

Tool has good psychometric properties compared with existing measures

Model estimating five-year MSD risk that includes sentinel lymph node status provides greater net benefits across treatment thresholds

No difference seen in change in PASI score, Physician Global Assessment score, self-administered PASI, Dermatology Life Quality Index

Fewer cases of melanoma, lower investigator-estimated risk class of skin cancer observed in atopic versus nonatopic individuals

39.1 percent of baricitinib 4-mg-treated patients with SALT score >20 at week 52 achieved SALT score ≤20 by week 104

Improvement seen in primary and key secondary end points, including peak pruritus numerical rating scale, sleep disturbance